These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort. Cao Y; Wang L; Ke S; Kelly CP; Pollock NR; Villafuerte Gálvez JA; Daugherty K; Xu H; Yao J; Chen Y; Liu YY; Chen X Microbiol Spectr; 2022 Aug; 10(4):e0136222. PubMed ID: 35867408 [TBL] [Abstract][Full Text] [Related]
43. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Theriot CM; Koumpouras CC; Carlson PE; Bergin II; Aronoff DM; Young VB Gut Microbes; 2011; 2(6):326-34. PubMed ID: 22198617 [TBL] [Abstract][Full Text] [Related]
44. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile. Collins DA; Riley TV Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124 [TBL] [Abstract][Full Text] [Related]
45. The Gut Microbiota Is Associated with Clearance of Clostridium difficile Infection Independent of Adaptive Immunity. Leslie JL; Vendrov KC; Jenior ML; Young VB mSphere; 2019 Jan; 4(1):. PubMed ID: 30700514 [No Abstract] [Full Text] [Related]
46. Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients. Søes LM; Brock I; Persson S; Simonsen J; Pribil Olsen KE; Kemp M Eur J Clin Microbiol Infect Dis; 2012 Feb; 31(2):185-92. PubMed ID: 21744281 [TBL] [Abstract][Full Text] [Related]
47. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes. Lesniak NA; Schubert AM; Sinani H; Schloss PD mSphere; 2021 May; 6(3):. PubMed ID: 33952668 [TBL] [Abstract][Full Text] [Related]
48. Loss of Interleukin-10 (IL-10) Signaling Promotes IL-22-Dependent Host Defenses against Acute Clostridioides difficile Infection. Cribas ES; Denny JE; Maslanka JR; Abt MC Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33649048 [TBL] [Abstract][Full Text] [Related]
49. Protection from Clostridium difficile infection in CD4 T Cell- and polymeric immunoglobulin receptor-deficient mice. Johnston PF; Gerding DN; Knight KL Infect Immun; 2014 Feb; 82(2):522-31. PubMed ID: 24478068 [TBL] [Abstract][Full Text] [Related]
50. A commensal protozoan attenuates Clostridioides difficile pathogenesis in mice via arginine-ornithine metabolism and host intestinal immune response. Yang H; Wu X; Li X; Zang W; Zhou Z; Zhou Y; Cui W; Kou Y; Wang L; Hu A; Wu L; Yin Z; Chen Q; Chen Y; Huang Z; Wang Y; Gu B Nat Commun; 2024 Apr; 15(1):2842. PubMed ID: 38565558 [TBL] [Abstract][Full Text] [Related]
51. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence. Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467 [TBL] [Abstract][Full Text] [Related]
52. Laboratory diagnosis of Clostridioides (Clostridium) difficile infection in domestic animals: A short review. Carvalho GM; Ramos CP; Lobato FCF; Guedes RMC; Giaretta PR; Silva ROS Anaerobe; 2022 Jun; 75():102574. PubMed ID: 35472506 [TBL] [Abstract][Full Text] [Related]
53. Recurrent Clostridium difficile infections: the importance of the intestinal microbiota. Zanella Terrier MC; Simonet ML; Bichard P; Frossard JL World J Gastroenterol; 2014 Jun; 20(23):7416-23. PubMed ID: 24966611 [TBL] [Abstract][Full Text] [Related]
54. MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammation. Bobo LD; El Feghaly RE; Chen YS; Dubberke ER; Han Z; Baker AH; Li J; Burnham CA; Haslam DB Infect Immun; 2013 Mar; 81(3):713-22. PubMed ID: 23264053 [TBL] [Abstract][Full Text] [Related]
55. Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Jarchum I; Liu M; Shi C; Equinda M; Pamer EG Infect Immun; 2012 Sep; 80(9):2989-96. PubMed ID: 22689818 [TBL] [Abstract][Full Text] [Related]
56. Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile. Cowardin CA; Kuehne SA; Buonomo EL; Marie CS; Minton NP; Petri WA mBio; 2015 Jan; 6(1):. PubMed ID: 25626905 [TBL] [Abstract][Full Text] [Related]
57. Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection. Warren CA; Li Y; Calabrese GM; Freire RS; Zaja-Milatovic S; van Opstal E; Figler RA; Linden J; Guerrant RL Infect Immun; 2012 Dec; 80(12):4463-73. PubMed ID: 23045479 [TBL] [Abstract][Full Text] [Related]
58. The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model. Yang XQ; Zhao YG; Chen XQ; Jiang B; Sun DY BMC Gastroenterol; 2013 Jul; 13():117. PubMed ID: 23865596 [TBL] [Abstract][Full Text] [Related]
59. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity. Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563 [TBL] [Abstract][Full Text] [Related]
60. Protective role of commensals against Clostridium difficile infection via an IL-1β-mediated positive-feedback loop. Hasegawa M; Kamada N; Jiao Y; Liu MZ; Núñez G; Inohara N J Immunol; 2012 Sep; 189(6):3085-91. PubMed ID: 22888139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]